Skyway Urban Air Mobility Systems Market 2025: 18% CAGR Driven by Smart City Integration & eVTOL Adoption
Biometric Authentication Modules Market 2025: Rapid Growth Driven by AI Integration & 18% CAGR Forecast
Wall Street Hedge Funds Turbocharge Bets on Sana Biotechnology—Should You Buy In?
America’s Biotech Revolution Starts in North Carolina: Inside the Roadshow Uniting Innovation, Jobs, and Security
Biotech Boom: North Carolina Lands Billions in Investments and Eyes Global Leadership
TipRanks Users Beware: Accounts Disabled for Suspicious Activity—Here’s What You Need to Know in 2025
Biotech Breakthroughs: Lawmakers Chart Bold Strategies for the Next Wave of Innovation
Pipeline Integrity Engineering Market 2025: AI-Driven Monitoring Spurs 7% CAGR Growth Through 2030
Bidirectional Brain-Computer Interface Market 2025: Surging Demand Drives 28% CAGR Through 2030
Ampacity Monitoring Systems 2025: Power Grid Intelligence Set to Surge 18% CAGR
Minos Biosciences, based in Paris, addresses the challenges of drug discovery and disease understanding with their innovative platform, MinoSuite™. MinoSuite™ utilizes CAGE-tag™ microfluidic technology, providing
BlackRock strategically reduced its stake in Vir Biotechnology, selling over 1.5 million shares at $6.48 each, maintaining a holding of just over 10.80%. This move
The United States is preparing to enhance its leadership in biotechnology through the proposed National Biotechnology Initiative Act. The Act, a bipartisan effort, seeks to
The fusion of artificial intelligence and biotechnology is transforming medical science, with AI predicting diseases and personalizing treatments. The AI in Biotechnology Market is projected
Gloucester, Massachusetts, historically a fishing hub, is transforming into a center for marine biotechnology innovation. Gloucester Marine Genomics Institute (GMGI) is advancing marine science, studying
The Rosen Law Firm is spearheading a legal campaign against Sana Biotechnology, Inc., focusing on potential breaches in investor rights. Investors who bought Sana stocks
Sana Biotechnology experiences a significant stock drop amid corporate restructuring, raising investor concerns. The company scales back oncology projects and reduces its workforce, impacting investor
The NSCEB’s strategy aims to enhance U.S. leadership in biotechnology, countering global competition, especially from China. A National Biotechnology Coordination Office (NBCO) is proposed to
Curiosity and online activity can be mistaken for misconduct by vigilant algorithms. These algorithms protect digital platforms from strain, fraud, and misuse but may misinterpret
23andMe has filed for Chapter 11 bankruptcy, raising concerns about the handling of genetic data from its 15 million customers. The House Committee on Energy
